Promising therapeutic effect of thapsigargin nanoparticles on chronic kidney disease through the activation of Nrf2 and FoxO1

Fong-Yu Cheng; Yu-Hsuan Lee; Yung-Ho Hsu; I-Jen Chiu; Yu-Jhe Chiu; Yuh-Feng Lin; Hui-Wen Chiu

doi:doi:10.18632/aging.102437

← Back

Research Paper Volume 11, Issue 21 pp 9875—9892

Promising therapeutic effect of thapsigargin nanoparticles on chronic kidney disease through the activation of Nrf2 and FoxO1

Figure 2. The morphology and TG release profile of TG NPs and KIM-1-TG NPs. (A) TEM images of the TG NPs and KIM-1-TG NPs. (B) In vitro TG release profile of the TG NPs and KIM-1-TG NPs incubated at 37°C in PBS (pH 5.5 and 7.4).